Author Archives: Robin Brisbourne

New approaches to understanding Alzheimer’s and Parkinson’s disease

In a study presented today at the Alzheimer’s Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explored how some people may develop the hallmarks of Alzheimer’s or Parkinson’s but never develop symptoms. Alzheimer’s is typified by the build-up of amyloid protein in the brain, and Parkinson’s disease by the loss of a key chemical messenger in the brain called dopamine. However, it’s becoming clear that individuals can exhibit these changes but show no changes in their memory, thinking or day-to-day function. Using brain imaging data from large-scale studies into both diseases, the team identified regions of the brain associated with resilience to these changes, such as a key region in the memory centre of the brain which was preserved despite the build-up of amyloid. By mapping these potential protective networks in the brain, the researchers hope to identify potential new approaches to treat the disease as well as ways to indicate those most at risk.

Genetic and non-genetic resilience against memory decline and Alzheimer’s

Researchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer’s, while others don’t. At AAIC2016, two teams of researchers are presenting findings revealing clues to genetic and non-genetic factors influencing a person’s resilience to memory decline and Alzheimer’s.

UCL reception marks launch of Drug Discovery Institute

Today saw an important event in the evolution of the Alzheimer’s Research UK Drug Discovery Alliance with a London reception to mark the launch of the UCL Drug Discovery Institute. Part of a network of three Institutes, the UCL Drug Discovery Institute will work with its counterparts at the Universities of Oxford and Cambridge to support the translation of cutting-edge academic science towards new treatments for dementia. The event, hosted by UCL and Alzheimer’s Research UK, saw several speakers take to the stage to discuss current efforts in dementia research at the university and reflect on the importance of the charity’s investment.

Mouse study sheds new light on memory loss in Alzheimer’s

US researchers have used a genetic technique in mice to reveal that early memory problems in Alzheimer’s are likely to be caused by difficulties retrieving memories, rather than laying down new ones. The research highlights particular cells in the brain that could be responsible for retrieving memories, which could be targeted by future treatments against the disease. The findings are published on 16 March in the journal Nature.